Anti-Dementia Drugs-Related Changes in Gait Performance While Single and Dual Tasking in Patients with Alzheimer Disease: A Meta-Analysis

被引:11
作者
Beauchet, O. [1 ]
Launay, C. P. [2 ]
Montero-Odasso, M. [3 ,4 ,5 ]
Annweiler, C. [2 ,6 ]
Allali, G. [7 ,8 ,9 ]
机构
[1] McGill Univ, Jewish Gen Hosp, Div Geriatr Med, Dept Med, Montreal, PQ H3T 1E2, Canada
[2] Angers Univ Hosp, UNAM, Dept Neurosci, Div Geriatr Med,UPRES EA 4638, Angers, France
[3] Univ Western Ontario, Lawson Hlth Res Inst, Parkwood Hosp, Gait & Brain Lab, London, ON, Canada
[4] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med, London, ON, Canada
[5] Univ Western Ontario, Schulich Sch Med & Dent, Div Geriatr Med, London, ON, Canada
[6] Univ Western Ontario, Schulich Sch Med & Dent, Dept Med Biophys, Robarts Res Inst, London, ON, Canada
[7] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland
[8] Univ Geneva, CH-1211 Geneva 4, Switzerland
[9] Yeshiva Univ, Albert Einstein Coll Med, Div Cognit & Motor Aging, Dept Neurol, Bronx, NY USA
关键词
Alzheimer disease; anti-dementia drugs; dual task; gait disorders; meta-analysis; older adults; MILD COGNITIVE IMPAIRMENT; OLDER; VARIABILITY; FALLS; PREVALENCE; GUIDELINES; MEMANTINE; DEMENTIA; RISK; INDIVIDUALS;
D O I
10.2174/1567205012666150710111341
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The effects of anti-dementia drugs on gait performance in Alzheimer disease (AD) are questionable. The objective of this meta-analysis was to examine the effects of anti-dementia drugs on the mean value and the coefficient of variation (CoV) of stride time among patients with AD while taking into account the type of drugs (i.e., acetylcholinesterase inhibitors [AChEIs] versus memantine) and the walking conditions (i.e., single versus dual-task). Methods: An English and French Medline search was conducted in March 2015, with no limit of date, using the Medical Subject Headings terms "pharmaceutical preparations" combined with terms "Pharmaceutical preparations" OR "Therapeutic uses" OR "Drug substitution" OR "Drugs essential" OR "Drugs, Generic" OR "Psychotropic drugs" combined with "Delirium" OR "Dementia" OR "Amnestic" OR "Cognitive disorders" AND "Gait" OR "Gait Ataxia" OR "Gait disorders, Neurologic" OR "Gait apraxia". Fixed-effects meta-analyses were used to examine anti-dementia drugs-related changes in mean value and CoV of stride time. Results: Of the 66 identified abstracts, 5 (7.6%) were included in the meta-analysis. Inter-group comparison of between-visit change underscored a significant decrease in CoV of stride time (P<0.004) in intervention group compared to control group, whatever the pooled analysis considered, but no significant change in the mean value (P>0.06). Intra-group changes in stride time parameters following the use of anti-dementia drugs showed a significant decrease for memantine (P<0.001) and while pooling AChEIs and memantine (P<0.001) under single task condition. Under dual task condition, only AChEIs improved significantly stride time parameters (P=0.002). Conclusion: Anti-dementia drugs demonstrated a significant improvement of gait performance with specific class effect depending on the walking conditions and on the type of stride time parameters considered.
引用
收藏
页码:761 / 771
页数:11
相关论文
共 39 条
  • [1] The Neural Basis of Age-Related Changes in Motor Imagery of Gait: An fMRI Study
    Allali, Gilles
    van der Meulen, Marian
    Beauchet, Olivier
    Rieger, Sebastian W.
    Vuilleumier, Patrik
    Assal, Frederic
    [J]. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2014, 69 (11): : 1389 - 1398
  • [2] Prevalence and severity of gait disorders in Alzheimer's and non-Alzheimer's dementias
    Allan, LM
    Ballard, CG
    Burn, DJ
    Kenny, RA
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2005, 53 (10) : 1681 - 1687
  • [3] Motor cortex and gait in mild cognitive impairment: a magnetic resonance spectroscopy and volumetric imaging study
    Annweiler, Cedric
    Beauchet, Olivier
    Bartha, Robert
    Wells, Jennie L.
    Borrie, Michael J.
    Hachinski, Vladimir
    Montero-Odasso, Manuel
    [J]. BRAIN, 2013, 136 : 859 - 871
  • [4] [Anonymous], PLOS MED
  • [5] Galantamine improves gait performance in patients with Alzheimer's disease
    Assal, Frederic
    Allali, Gilles
    Kressig, Reto W.
    Herrmann, Francois R.
    Beauchet, Olivier
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (05) : 946 - 947
  • [6] Changes in Gait Variability with Anti-dementia Drugs: A Systematic Review and Meta-analysis
    Beauchet, O.
    Launay, C. P.
    Allali, G.
    Annweiler, C.
    [J]. CNS DRUGS, 2014, 28 (06) : 513 - 518
  • [7] Beauchet O, 2013, EUR J PHYS REHAB MED, V49, P857
  • [8] Gait variability at fast-pace walking speed: A biomarker of mild cognitive impairment?
    Beauchet, O.
    Allali, G.
    Launay, C.
    Herrmann, F. R.
    Annweiler, C.
    [J]. JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (03) : 235 - 239
  • [9] Beauchet O, 2011, J NUTR HEALTH AGING, V15, P79, DOI [10.1007/s12603-011-0016-6, 10.1007/s12603-011-0062-0]
  • [10] Stops walking when talking: a predictor of falls in older adults?
    Beauchet, O.
    Annweiler, C.
    Dubost, V.
    Allali, G.
    Kressig, R. W.
    Bridenbaugh, S.
    Berrut, G.
    Assal, F.
    Herrmann, F. R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (07) : 786 - 795